Podcasts about Wellcome

After this week's announcement that under-16s will be banned from major social media platforms, we delve into the evidence behind the ban with Professor Amy Orben, Programme Leader of the Digital Mental Health Group at the University of Cambridge, and Dr Catherine Sebastian, Head of Evidence at Wellcome. Also on the show, what can penalty shoot-outs teach us about international diplomacy? And how does the valuation of a football player impact the number of crashes seen after their team plays? Professor of Mathematical Sciences at Bath and football fan, Kit Yates, joins Tom to assemble their very own World Cup squad of science. Presenter: Tom Whipple Producers: Kate White, Katie Tomsett, Keiran Manetta-Jones Editor: Martin Smith Production Co-ordinator: Jana Bennett-Holesworth

On this episode of Culture & Compliance Chronicles, Nitish Upadhyaya from Ropes & Gray's Insights Lab and Richard Bistrong of Front-Line Anti-Bribery, are joined by Fraser Simpson, enterprise strategy lead at the Wellcome Trust, to explore how organizations can make governance and compliance more human. The conversation delves into the importance of shaping ethical cultures that go beyond policies and procedures, focusing on real human behavior, creativity, and engagement. Fraser shares insights from Wellcome's innovative “speak-up” program and the creation of Connie, a puppet character designed to spark ethical conversations and strengthen judgment across the organization. The episode also discusses the challenges and opportunities presented by technology and AI in compliance, emphasizing the need to support—not replace—human judgment.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a report showed patients in Europe face barriers to patient access. Elsewhere, Wellcome prizes are facilitating research in both tropical disease and mental health.  You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Heat is one of the most dangerous natural hazards, causing preventable deaths and putting vulnerable communities under increasing pressure. But heat is not experienced equally, with some communities more vulnerable than others.The University of Liverpool's Melting Metropolis research is a major Wellcome funded project that explores how people experience urban heat, and how cities can respond. It brings together historians, artists, and community engagement experts to better understand heat and health in London, New York and Paris.Host Gavin Freeborn is joined in the studio by Professor Chris Pearson, Environmental Historian and Principal Investigator on the project, and Dr Anna Bocking-Welch, Senior Lecturer in History, to talk about the realities of extreme heat, and what cities need to do next. The clips are John Nairn, Senior Extreme Heat Advisor, World Meteorological Organization talking at a UN (United Nations) conference, and Dr Chloe Duteil, Melting Metropolis, University of Liverpool. More information available at liverpool.ac.uk/research/original-ideas/      

In this episode, I am  joined by Sarah Stock, Professor and Consultant in Maternal and Fetal Health, and one of the leading global voices in stillbirth and preterm birth research. Sarah's work spans laboratory science, clinical trials, and large-scale international data-driven research focused on improving outcomes for mothers and babies worldwide.Sarah earned her MD from Manchester University Medical School and her PhD in Reproductive Biology from the University of Edinburgh, later completing specialist and subspecialist Maternal and Fetal Medicine training across Edinburgh, Glasgow, London, and Australia.Sarah currently serves as Program Director at Wellcome Leap, where she leads the $50M In Utero program  an ambitious initiative aiming to reduce stillbirth rates by 50% by building scalable technologies that can measure, monitor, and predict fetal development in real time.Stillbirth affects more than 2 million families every year  roughly one baby every 16 seconds  yet it remains one of the most overlooked global health challenges. In this conversation, we explore why pregnancy care has remained largely unchanged for decades, how emerging technologies could transform maternal and fetal care, and where founders and innovators can create meaningful impact.In this episode, we discuss:• Sarah's journey into maternal–fetal medicine and stillbirth research• Why stillbirth continues to be a neglected global health crisis• The vision behind Wellcome Leap's In Utero program• How the ARPA-style innovation model differs from traditional research funding• Technologies needed to measure placental, maternal, and fetal health at scale• Wearables, AI, biomarkers, and the future of pregnancy monitoring• Challenges founders face in women's health and maternal care• How Wellcome Leap supports breakthrough innovation beyond funding alone• The biggest market opportunities in women's health over the next 3–5 years• What success looks like for the future of maternal healthcare• How founders and researchers can engage with the ecosystemIf you're a founder, investor, researcher, healthcare leader, or someone passionate about women's health innovation, this episode offers an inside look at one of the biggest opportunities to reshape the future of healthcare.This episode is brought to you in partnership with FemTech India a global women's health ecosystem building and scaling startups to close the gender gap in emerging markets like India.Disclaimer: The content shared in this episode is intended for general awareness and discussion purposes only. It should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal health decisions. ©️TechThrive Ventures. All rights reserved.Newsletter - https://techthrivenewsletter.beehiiv.com/Sarah Stock - https://www.linkedin.com/in/sarah-stock-92605449/Wellcome Leap $50M Utero program - https://wellcomeleap.org/inutero/ Connect with us Instagram: ⁠⁠https://www.instagram.com/ctrl.alt.thrive.podcast/⁠⁠ Youtube :⁠⁠⁠ ⁠https://www.youtube.com/@Ctrlaltthrive/videosConnect with Navneet Linkedin : ⁠⁠https://www.linkedin.com/in/navneet-kaur-80109b227/⁠⁠Instagram : ⁠⁠https://www.instagram.com/nav_neeetkaur/⁠

In der caritalks-Episode 116 haben wir schon über das Wellcome-Projekt berichtet. Wir sprachen mit Diane Nottbohm, die die Arbeit in Oberhausen koordiniert. Im Mittelpunkt der Aktivitäten steht hier die praktische Hilfe für Familien nach der Geburt eines Kindes. Diese Hilfe wird von Ehrenamtlichen geleistet, die über die Wellcome-Koordinatorinnen vermittelt und begleitet werden. Eine Ehrenamtliche, die das tut, ist Gabriele Hömig-Kaspar. Die 67-Jährige kümmert sich ein- bis zweimal in der Woche jeweils für ein paar Stunden um die kleine Tilda und entlastet dadurch die junge Familie. Sie ist eine von 15 „Wellcome-Engeln", die in Oberhausen ein- bis mehrmals in der Woche die Sorge um ein neugeborenes Kind übernehmen und so den Eltern Freiräume schaffen. Wie wichtig das ist, erzählt Felix, der Papa der kleinen Tilda, in dieser Episode. Felix ist Ingenieur und gelegentlich zu Auslandsaufenthalten unterwegs, sodass die Sorge um die kleine Tilda für ihre Mama schon sehr fordernd sein kann. Zumal die Großeltern weit entfernt wohnen und nicht „mal eben" unkompliziert einspringen können. Wie gut, dass es Gabriele Hömig-Kaspar gibt, die dann mit der Kleinen auf den Spielplatz geht, Ausflüge unternimmt oder sie mit ihren Enkeln spielen lässt. Hömig-Kaspar ist Rentnerin, hat lange als Krankenschwester und später in der Reisebranche gearbeitet und ist die Arbeit mit Menschen gewohnt. Die dreifache Oma genießt es, außer bei ihren Enkelkindern auch bei der kleinen Tilda zu erleben, wie sie sich entwickelt. Personen: Gabriele Hömig-Kaspar ist dreifache Oma und Mutter zweier Kinder ist vielfach ehrenamtlich engagiert: Sie betreut eine weitere Familie und ist Lese-Oma in einer Schule. Sie hat 18 Jahre als Krankenschwester gearbeitet und als Reisekauffrau ein Reisebüro geleitet. Wellcome: Wellcome bietet neben der praktischen Hilfe nach der Geburt eine Online-Plattform für pädagogische Beratung, Übernachtungsmöglichkeiten für Elternteile, die nach einer Trennung in räumlicher Distanz zu ihren Kindern leben, und in Einzelfällen finanzielle Hilfen für Familien in Not. Weitere Infos: https://www.wellcome-online.de/ Ehrenamt gesucht? www.caritas-ehrenamtsportal.de

Kindern geht es nur gut, wenn es auch den Eltern gut geht. So lautet die Leitidee des Sozialunternehmens „Wellcome". Die Caritas Oberhausen ist, gemeinsam mit dem Evangelischen Familien- und Erwachsenenbildungswerk, einer von über 200 Wellcome-Standorten im deutschsprachigen Raum. Diane Nottebohm von der Caritas und ihre Kollegin Ille Lauterfeld koordinieren die Arbeit von Wellcome in Oberhausen. 15 ehrenamtliche „Wellcome-Engel" übernehmen stundenweise ein- bis mehrmals in der Woche die Sorge um das Kind und schaffen so den Eltern Freiräume. Christoph Grätz hat Diane Nottebohm besucht. Sie berichtet, wie Ehrenamtliche Familien bis etwa ein Jahr nach der Geburt begleiten und entlasten. Wellcome setzt als präventive Hilfe ein, bevor größere Probleme entstehen, und ergänzt andere Frühe Hilfen des Jugendamts sowie die Schwangerenberatung und Erziehungsberatung der Caritas. Die Wellcome-Hilfen Von der Hamburger Zentrale aus werden weitere Angebote koordiniert: digitale Elternabende und pädagogische Beratung (Onlineplattform ElternLeben) sowie Übernachtungsmöglichkeiten für Elternteile, die nach einer Trennung in räumlicher Distanz zu ihren Kindern leben (Bereich Kindwärts). Finanzielle Unterstützung durch Gutscheine – für Kleidung, Ausstattung, zum Schulstart und zu Weihnachten – ist über den Wellcome-Spendenfonds ebenfalls möglich. Infos zu Wellcome https://www.wellcome-online.de/

Wellcome along we have put together a deep, sophisticated blend of Nu Jazz, Broken Beat, and Contemporary Soul.There is a clear "London meets world" vibe here—mixing the rhythmic complexity of artists like Kaidi Tatham and Lay-Far with the spiritual, cinematic textures of Hidden Orchestra and Alina Bzhezhinska. Ending with classics from Roy Hargrove and Robert Glasper gives the list a grounded, timeless feel.We feel it's the perfect soundtrack for a late-night lounge set.Aja & ClaireMelchyor A - Dune (Melchyor A's Djazz Version)Lay-Far Dance Orchestra - Take Flight (Part 1).Georgie Sweet - Become New (Kaidi Tatham Remix)Q Jazztek- Quiet Dance (Midnight Flo)Sweatson Klank - Sun ShowersOuter Worlds Jazz Ensemble - Alto VentoAlina Bzhezhinska Tulshi - Journey Home (Cosmic Analog Ensemble Remix)Minka- Attention.Outer Worlds Jazz Ensemble - All isPanoptikum - Hamid Drake Michael Zerangframe Drum Panoptikum Arkestra Peaceful RemixMagic Water - Frank Blythe 4Q FRemixHadley Caliman - WatercressChicago Soul Jazz Collective - Message To A ChildRoy Hargrove - Divine   Lp Earfood 2009The Terry Hsieh Collective - River Of The Fire GoddessHidden Orchestra - Dust Floex RemixJulien Dyne - Falling Down feat. Parks.wlStee Downes-AsunderTuomo - True FriendsRobert Glasper Experiment - Black Radio feat. Yasiin BeyAhmed Sirour & Cleveland P. Jones - Afro BlueKoop - Baby (feat Cecilia Stalin)Zuco 103 - Treasure

Wellcome to BodybyMali @ Malifreebirds   Podcast - A continuing story of a health and wellness journey In today's episode, We will be talking with Chelsea and Jeff who owners of FloBella LLCThe topic is LOVE on our 4 part series .Let's talk about what love looks like in the eyes of these two beautiful souls Tap in and enjoy!! For more information you can find them on all social media platforms or click on their links below :https://youtube.com/@theflobellaway?si=V_2pcImqF4kBFW3rhttps://www.facebook.com/share/1CKVHCJjPM/?mibextid=wwXIfrThank you for joining me in this week's Episode of FloBella LoveFor more information on Love and other wonderful topics of health and wellness with Malifreebird's Podcast, you can find me on all social media platforms or login to the links below: https://youtube.com/@malij_?si=vN7FfiWdf_qTqGZ-https://www.instagram.com/mali_freebird?igsh=MWluMHlqdG44MzkyNw%3D%3D&utm_source=qrhttps://youtube.com/@malij_?si=vN7FfiWdf_qTqGZ-for more information!I'm Mali FreeB Byrd, strive to live a more balanced lifestyle. And as my father used to say,“  to help bring good into the world”. 

In this episode Professor Tom Fardon returns to Clinical Conversations to discuss updates in asthma diagnosis and management from the joint BTS/SIGN/NICE guideline on Asthma. Prof Fardon and Dr Ben Warner discuss the changes to practice since the guidelines were released and the evolving role of biologics in asthma treatment. Professor Fardon is a Consultant Respiratory Physician at NHS Tayside and Honorary Professor at the University of Dundee. They are also the chair of the Scottish Severe Asthma Group within the Centre for Sustainable Delivery. Dr Ben Warner is a Respiratory Medicine Specialty Registrar with clinical and academic experience of global public health. He is currently undertaking a PhD in multimorbidity in Malawi as part of the Wellcome-funded Multimorbidity PhD Programme for Health Professionals with the University of Glasgow. Recording Date: 9 December 2025 --Links-- BTS/SIGN/NICE guideline on Asthma - https://www.nice.org.uk/guidance/ng245 Asthma Pathway - https://www.nice.org.uk/guidance/ng244 Algorithm A: Objective tests for diagnosing asthma in adults and young people (aged over 16 years) - https://www.nice.org.uk/guidance/ng245/resources/bts-nice-and-sign-algorithm-a-summary-of-objective-tests-for-diagnosing-asthma-pdf-13556516365 Algorithm C: Pharmacological management of asthma in people aged 12 years and over - https://www.nice.org.uk/guidance/ng245/resources/algorithm-c-pharmacological-management-of-asthma-in-people-aged-12-years-and-over-bts-nice-pdf-13556516367 ‘Optimising inhaled therapy for patients with asthma'- https://doi.org/10.1136/bmj-2024-080353 Asthma+Lung UK website Inhalers resource - https://www.asthmaandlung.org.uk/living-with/inhaler-videos ‘Greener Practice' asthma care toolkit (free registration required)- https://www.greenerpractice.co.uk/asthma-toolkit/ 'Greener Practice' Device Choice video - https://www.youtube.com/watch?v=YRJGD48bryI Asthma Guidelines (Plain Language Version) - https://www.sign.ac.uk/patient-public-involvement/plain-language-versions-of-guidelines/asthma/ -- Follow us -- https://www.instagram.com/rcpedintrainees https://x.com/RCPEdinTrainees -- Upcoming RCPE events -- https://www.rcpe.ac.uk/events -- Become an RCPE Member -- https://www.rcpe.ac.uk/membership/join-college Feedback: cme@rcpe.ac.uk This podcast is from the Trainees & Members' Committee (T&MC) of the Royal College of Physicians of Edinburgh (RCPE).

▼ Follow Nicksher Music: » Spotify Playlist: https://open.spotify.com/playlist/4dI7kNNcEGQ8MSGLYVh39T?si=Zg1yjJAHTASjK7xa5S-Lew » Beatport: classic.beatport.com/label/nicksher-music/57468 » YouTube: www.youtube.com/channel/UCcTF27v-cpxlBfLdQODpFTw » Facebook: www.facebook.com/groups/1706975586219784/ » SoundCloud: @nickshermusic » VK: vk.com/club123650463 » Instagram: https://www.instagram.com/nickshermusic/ --- ▼ Follow Great Lion: SoundCloud: @great-lion Facebook: https://www.facebook.com/ilyapetroff051/

Wellcome to Monday flogs.....it may be the worst day of the week but strap in and let us turn that frown upside down.We hear about a bit of Mullumbimby madness with some public pissing.Weirdest places you've copulated and Amazing Grace gets a run for her money with another wild name parents have called their kids. Another truckload of winning & non-winning pickup lines and Y62 drivers towing caravans cop a spray from our favourite hot-blooded bone-themed truckie.Enjoy legend! Hosted on Acast. See acast.com/privacy for more information.

Send us a textIn this episode, Jeremy Farrar, FRS, of the World Health Organization (WHO), joins new hosts Rebecca Alvania, PhD, MA, MPH, and Robert H. Hopkins, Jr., MD, for an insightful conversation on the power of science, the importance of community, and the urgent need for trust and collaboration in an increasingly polarized world. Drawing on decades of experience—from the early days of HIV/AIDS to pandemic preparedness, vaccine development, and global health leadership—Dr. Farrar shares personal lessons on failure, leadership under pressure, and why optimism, humility, and inclusion are essential to shaping the future of public health.Show NotesA physician-scientist, international health leader, and advocate, Dr. Farrar's work has spanned HIV/AIDS, research on avian influenza, and leadership at Wellcome, where he helped guide the global response to the COVID-19 pandemic. He now serves as assistant director-general of health promotion and disease prevention and control at WHO, providing leadership on infectious and noncommunicable diseases, health promotion, food safety, and the health impacts of environmental change. In 2019, NFID honored him with the Jimmy and Rosalynn Carter Humanitarian Award in recognition of his outstanding contributions to global public health. TranscriptAlvania:Welcome to the NFID podcast, Infectious IDeas. This is Rebecca Alvania, NFID CEO, and with me is my co-host, NFID Medical Director, Dr. Bob Hopkins. Hopkins:Hey, happy to be here, Rebecca. Alvania:Our guest today is Dr. Jeremy Farrar. He serves as the World Health Organization's Assistant Director-General of health promotion and disease prevention and control. Many of you know him for his groundbreaking work on infectious diseases with pandemic potential. He's also held major leadership roles, including director of the Welcome Trust and co-founder of Coalition for Epidemic Preparedness Innovations (CEPI), the global effort to speed vaccine development and ensure access worldwide. In 2019, NFID honored him with the Jimmy and Rosalynn Carter Humanitarian Award. It recognized his impact on global public health and his commitment to making the world a more equitable place. Jeremy, thank you so much for joining us. Farrar:Great pleasure. Alvania:All right, we're going to start at the beginning. You began your career working in HIV AIDS. How did those early experiences shape you as a scientist?Farrar:That would have been in the late 1980s and of course, that was the time that HIV was becoming known about. And I do remember—I was a medical student, and soon after graduating—just the impact this had. I was working in London at the time, and medical students and doctors had got used to the idea that many things were treatable, and then suddenly you had mostly young individuals coming in. And frankly, there was very little anybody could do. Obviously, we didn't know what the cause was, and that was devastating, actually. But also on the positive side, as a result of great science and great public health, some solutions did start to come, and I pay huge tribute to the community who were then known to be living with HIV, because the role they played in pushing science and pushing public health was, I think, absolutely groundbreaking. And I'm not sure the establishment would have got there quite the way it did without that pressure from the community. So, three lessons: one, is the devastating impact of something new, in this case, HIV. Secondly, the incredible power of science. And thirdly, the critical importance of communities being part of engagFollow NFID on social media

Wellcome back to Courageous Leadership with Virginia Prodan #Podcast. John Gordon - is our guest  John Gordon is a Legal Analyst, Host of the Palm Beach–based, nationally syndicated radio show and podcast The Truth with John Gordon.    Our discussion  will focus on being united in America and what we can do about creating that unity in our family, business, community and in America.  I am Virginia Prodan —an #international #humanrights #attorney, #keynote #speaker, #author of *Saving My Assassin*, and survivor of socialist Romania. I know firsthand the price of freedom, the power of faith, and the courage it takes to stand for truth in the face of opposition. On this channel, you'll find weekly episodes that inspire and equip you to: - Strengthen your #Christian #faith and live with bold #courage - Defend #freedom and #values in an increasingly hostile culture - Learn powerful lessons from history—especially from life under socialism - Discover your God-given purpose and calling - Lead with conviction at home, in the church, and in society - Learn powerful lessons from history—especially from life under socialism - Discover your God-given purpose and calling - Lead with conviction at home, in the church, and in society.   Whether you're searching for encouragement, answers to cultural challenges, or practical steps to live boldly in your faith, this channel will equip you to stand strong.          Subscribe for free to Courageous Leadership with Virginia Prodan #Podcast at: https://open.spotify.com/show/7kHPeoAgbkAHCg2C6RApEZ - hear encouraging & inspiring messages.   

Wellcome to Derry Miami Vice Gremlins 3 Con Jorge Aguilar.

Wellcome to Derry Miami Vice Gremlins 3 Con Jorge Aguilar.

We Mean Well is coming to New Zealand and performing live at The Bruce Mason Centre Friday November 21st! Get your tickets here, Whanau: https://www.aucklandlive.co.nz/show/we-mean-wellCome join us on the Patreon and enjoy a little more of your podcasting Mummy & Daddy for just $2.50 per week!For more info, follow the link: https://www.patreon.com/c/wemeanwell Lulu's Birthday, Perth Pina Coladas & Lulu Tricks Wumpy With One Of The Great Switch Ups!The Round UpGiftsPerthHotlines Hosted on Acast. See acast.com/privacy for more information.

Written by Hannah KhalilIn 2040, a Middle Eastern nation is struggling to survive rising temperatures and rolling power cuts. Architect Noura Halim has devoted her life to designing a new kind of city, one that could protect people from the worsening climate and keep her country alive. But as construction begins, the project drains the nation's fragile resources, workers are pushed to breaking point, and her teenage daughter Amal begins to question everything her mother believes in.As tensions rise at home and across the country, Noura must confront the cost of her own ambition and the possibility that her dream of salvation could destroy the very place she's trying to save.Tipping Point was developed through OKRE Experimental Stories supported by Wellcome in consultation with Dr Robert Hughes of the London School of Hygiene and Tropical Medicine, and Dr Candice Howarth of the London School of Economics.Cast:Noura . . . . . Nadia Albina Amal . . . . . Eleanor Nawal Steve . . . . . Clive Hayward Mr Felix . . . . . Angus Wright Jamila . . . . . Tanvi Virmani TV Presenter . . . . . Jasmine Hyde Noura's Assistant . . . . . Sasha McCabeProduction co-ordinators: Sara Benaim and Emma Donald Sound design: Sharon Hughes Director: Sasha Yevtushenko

Send us a textIn this powerful episode, I sit down with Holly, a remarkable professional who transforms her harrowing journey through anorexia into a mission of mental health advocacy. From battling a life-threatening eating disorder as a teenager to now leading digital mental health technology regulation, Holly shares an intimate and inspiring story of survival, resilience, and purpose. Holly Coole is Senior Manager for Digital Mental Health at the MHRA and lead forthe Wellcome-funded project to explore the clinical evaluation and regulation ofdigital mental health technologies. She has also worked for NHS Supply Chain asthe Patient Safety and Innovation Manager. Holly has a background in psychiatricnursing, previously working for Nottinghamshire Healthcare NHS Foundation Trustas a Community Psychiatric Nurse for several years along with experience in anumber of mental healthcare services such as inpatient forensic, older adults andchild and adolescent mental health. Holly has also undertaken training in cognitivebehavioural therapy and brings her own insights to lived experience of mental health.Holly sincerely discusses her struggles with perfectionism, her cyclical recovery, and how she's turned her most challenging experiences into a force for positive change.This episode offers a raw, honest look at mental health, breaking stigmas, and finding hope when all seems lost. You will be moved by Holly's courage and insights into self-compassion, personal growth, and the importance of supporting those battling mental health challenges.If you've ever felt trapped by your own expectations, this episode will set you free.Watch it on YouTube: https://youtu.be/6MonJ7Rnca4Don't forget to "Like and Subscribe", so we can reach more people to help.Visit www.mindandmood.co.uk, email info@mindandmood.co.ukor call us on +44 (0)207 183 6364 to find out more.#MentalHealthAwareness #EatingDisorderRecovery #SelfCompassion #MentalHealthJourney #WellnessTechnology #Resilience #BreakTheStigma #MentalHealthAdvocacy #PersonalGrowth #SelfLove #RecoveryStory #MentalHealthTech #Perfectionism #Healing #WomensHealth #MentalWellness #SurvivorsStory #DigitalHealth #MindBodyHealing #InspirationalStorySupport the show

In dieser Folge des Familien- und Bildungskompass spricht Fritjof mit Ilsabe von Campenhausen, der Geschäftsführerin von wellcome. Gemeinsam gehen sie der Frage nach, warum eine erfolgreiche Volkswirtschaft bindungsfähige Kinder braucht und welche Rolle Familien für eine gesunde Gesellschaft spielen. Ilsabe von Campenhausen betont, wie wichtig es ist, Familien frühzeitig zu unterstützen, bevor das sprichwörtliche Kind in den Brunnen gefallen ist. Sie zeigt auf, welche Strukturen und Hilfen notwendig sind, damit Eltern entlastet werden und Kinder stark ins Leben starten können. Ein inspirierendes Gespräch über Prävention, gesellschaftliche Verantwortung und die zentrale Bedeutung von Familie.Hier der Link zur Homepage von wellcome:wellcome l HomepageGerne könnt ihr mit Ilsabe von Campenhausen und Fritjof über LinkedIn in Kontakt treten:Fritjof Nelting LinkedInIlsabe von Campenhausen LinkedInWir kommen auch sehr gerne zu euch in die Schule, um mit euch und eurem Kollegium gemeinsam an einer gesunden Schullandschaft zu arbeiten - erfahrt hier mehr darüber.Falls ihr Lehrkraft oder SchulleiterIn seid, könnt ihr euch natürlich auch für den Newsletter anmelden und immer über Neuigkeiten informiert bleiben. Euch beschäftigt aktuell ein Thema, das eurer Meinung nach unbedingt im Rahmen des Podcasts besprochen werden sollte? Super, wir freuen uns jederzeit über euren Input! Schreibt uns euren Themenvorschlag oder eure Fragestellung einfach per Mail an info@neltings-welt.de.Viel Spaß mit der Folge.

On World Mental Health Day 2025, this powerful episode of Digital Health Unplugged delves into the importance of including the patient voice in the development of digital mental health technologies (DMHTs). Podcast host Jordan Sollof is joined by Holly Coole, senior manager for digital mental health at the Medicines and Healthcare products Regulatory Agency (MHRA), and Grace Gatera, a lived experience advocate with direct experience of trauma from surviving the 1994 Rwandan genocide. Coole discusses the three-year Wellcome-funded project she is leading, which aims to strengthen regulation and evaluation of DMHTs including apps, digital triage tools and virtual reality software. Joining from Rwanda, Gatera shares her first-hand understanding of mental health problems and the importance of including lived experience voices in digital mental health design and regulation. The two women are working together to ensure that DMHTs - including the use of AI - are effective, safe and take the needs of those who use them into account. Guests: Holly Coole, senior manager for digital mental health at the MHRA Grace Gatera, lived experience advisor from Rwanda with a global perspective on mental health access and the power of tech in underserved communities  

Sarah reports from the International Research Culture Conference #IRCC25 which was held at the University of Warwick on 17 September 2025. It features contributions from Rika Nair, Alys Kay and Dolly Coates, as well as excerpts from Sarah's talk on professional development for research enablers. Sarah and her guests talk about Why the recognising the contributions of research-adjacent roles is a key research culture issue Challenges research-adjacent professionals can face when trying to make progress in their careers The System Shuffle game which aims to make the hidden labour in research teams more visible How the language used to describe research-adjacent roles influences how they are perceived   Find out more Read the show notes and transcript on the podcast website Connect with Rika Nair, Alys Kay or Dolly Coates on LinkedIn Read Alys's LinkedIn post about the System Shuffle game Find out more about Research Culture Knowledge Exchange, IRCC25 and the work of the National Centre for Research Culture Read the Wellcome report ‘What researcher's think about the culture they work in'   About Research Adjacent Where are you listening from? Share a pic and tag @ResearchAdjacent on LinkedIn, Instagram or BlueSky Fill out the research-adjacent careers quiz Sign up to the Research Adjacent newsletter Email a comment, question or suggestion Leave Sarah a voice message

With all the Cardi B, Offset and Diggs talk going on maaaaaan I had to tap in.Women I have a question for y'all in this episode as wellCome catch these waves

With all the Cardi B, Offset and Diggs talk going on maaaaaan I had to tap in.Women I have a question for y'all in this episode as wellCome catch these waves

In this edition of The Naked Scientists, why we need to pay closer attention to antimicrobial resistance in some of the world's poorest nations... Like this podcast? Please help us by supporting the Naked Scientists

In this edition of The Naked Scientists, we look at 25 years of the Human Genome Project. What is it? And what has it achieved? Like this podcast? Please help us by supporting the Naked Scientists

Send us a textIn this episode Nathan chats to his friend Ian Edgeworth, author of the recent books "Wellcome to the Wonderful world of Air source Heat Pumps - What Kept You"  and "The Pocket Guide to Low Temperature Central Heating" You can find the books at New Perspectives.ComListen to Ian's journey into teaching and what he and Nathan think of the current situation regarding heat pump training.This season is being sponsored by Intergas who make the quality xylinder - a heat pump cylinderSupport the showLearn more about heat pump heating by followingNathan on Linkedin, Twitter and BlueSky

Audio FileGround Truths can also be found on Apple Podcasts, Spotify and YouTube.The UK is the world leader in human genomics, and laid the foundation for advancing medicine with the UK Biobank, Genomes England and now Our Future Health (w/ 5 million participants). Sir John Bell is a major force in driving and advising these and many other initiatives. After 22 years as the Regius Professor of Medicine at the University of Oxford he left in 2024 to be President of the Ellison Institute of Technology. Professor Bell has been duly recognized in the UK: knighted in 2015 and appointed Companion of Honor in 2023. In our conversation, you will get a sense for how EIT will be transformational for using A.I. and life science for promoting human health.Transcript with audio links Eric Topol (00:06):Hello, this is Eric Topol from Ground Truths. And I'm really delighted to welcome today, Sir John Bell who had an extraordinary career as a geneticist, immunologist, we'll talk about several initiatives he's been involved with during his long tenure at University of Oxford, recently became head of the Ellison Institute of Technology (EIT) in the UK. So welcome, John.Sir John Bell (00:30):Thanks, Eric. Thanks very much for having me.Eric Topol (00:34):Well, I think it's just extraordinary the contributions that you have made and continue to make to advance medicine, and I thought what we could do is get into that. I mean, what's interesting, you have had some notable migrations over your career, I think starting in Canada, at Stanford, then over as Rhodes Scholar in Oxford. And then you of course had a couple of decades in a very prestigious position, which as I understand was started in 1546 by King Henry VII, and served as the Regius Professor of Medicine at the University of Oxford. Do I have that right?Sir John Bell (01:11):It was actually Henry VIII, but you were close.Eric Topol (01:14):Henry VIII, that's great. Yeah. Okay, good. Well, that's a pretty notable professorship. And then of course in recent times you left to head up this pretty formidable new institute, which is something that's a big trend going on around the world, particularly in the US and we'll talk about. So maybe we can start with the new thing. Tell us more about the Ellison Institute of Technology (EIT), if you will.Sir John Bell (01:47):Yeah. So as you know, Larry Ellison has been one of the great tech entrepreneurs focused really on developing terrific databases over his career and through Oracle, which is the company that he founded. And Larry is really keen to try and give back something substantial to the world, which is based on science and technology. So he and I did quite a bit together over the Covid pandemic. He and I talked a lot about what we're doing and so on. He came to visit afterwards and he had, I think he decided that the right way to make his contributions would be to set up an institute that would be using the state-of-the-art science and technology with a lot of AI and machine learning, but also some of the other modern tools to address the major problems in healthcare, in food security, in green energy and climate change and in global governance.Sir John Bell (02:49):So anyway, he launched this about 18 months ago. He approached me to ask whether I would run it. He wanted to set it up outside Oxford, and he wanted to do something which is a bit different than others. And that is his view was that we needed to try and create solutions to these problems which are commercially viable and not all the solutions are going to be commercially viable, but where you can create those, you make them sustainable. So the idea is to make sure that we create solutions that people want to buy, and then if they buy them, you can create a sustainable solution to those issues. So we are actually a company, but we are addressing many of the same problems that the big foundations are addressing. And the big issues that you and I talk about in health, for example, are all on our list. So we're kind of optimistic as to where this will go and Larry's supporting the project and we're going to build out an institute here which will have about 5,000 people in it, and we'll be, I think a pretty exciting new addition to the science and technology ecosystem globally.Eric Topol (04:02):Well, I know the reverberations and the excitement is palpable and some of the colleagues I've spoken to, not just in England, but of course all over the world. So congratulations on that. It was a big move for you to leave the hardcore academics. And the other thing I wanted to ask you, John, is you had distinguished your career in immunology, in genetics, type 1 diabetes and other conditions, autoimmune conditions, and now you've really diversified, as you described with these different areas of emphasis at the new institute. Is that more fun to do it or do you have deputies that you can assign to things like climate change in other areas?Sir John Bell (04:50):Trust me, Eric, I'm not making any definitive decisions about areas I know nothing about, but part of this is about how do you set up leadership, run a team, get the right people in. And I have to say one of the really interesting things about the institute is we've been able to recruit some outstanding people across all those domains. And as you know, success is almost all dependent on people. So we're really pretty optimistic we're going to have a significant impact. And of course, we also want to take risks because not a lot of point in us doing stuff that everybody else is doing. So we're going to be doing some things that are pretty way out there and some of them will fail, so we are just going to get used to trying to make sure we get a few of them across the finish line. But the other thing is that, and you've experienced this too, you never get too old to learn. I mean, I'm sucking up stuff that I never thought I would ever learn about, which is fun actually, and really marvel.Eric Topol (05:55):It's fantastic. I mean, you've really broadened and it's great that you have the runway to get these people on board and I think you're having a big building that's under construction?Sir John Bell (06:07):Yeah, we've got the original building that Larry committed to is about 330,000 square feet of space. I mean, this is completely amazing, but we are of course to accommodate up to 5,000 people, we're going to need more than that. So we are looking at a much wider campus here that'll involve more than just that building. I think we'll end up with several million square feet of space by the time we're finished. So mean, it's a really big project, but we've already made progress in some domains to try and get projects and the beginnings of companies on the road to try and solve some of the big problems. So we're quite excited about it.Eric Topol (06:49):Now you, I assume it's pretty close to Oxford, and will you have some kind of inter interactions that are substantial?Sir John Bell (06:58):Yeah, so the university's been terrific about this actually, because of course most universities would say, well, why don't you do it inside the university and just give us the money and it'll all be fine. So of course Larry. Larry wasn't born yesterday, so I said, well, thank you very much, but I think we'll probably do this nearby. But the university also realized this is a really exciting opportunity for them and we've got a really good relationship with them. We've signed an agreement with them as to who will work where. We've agreed not to steal a lot of their staff. We're going to be bringing new people into the ecosystem. Some of the university people will spend some time with us and sometime in the university, so that will help. But we're also bringing quite a few new people into the setting. So the university has been really positive. And I think one of the things that's attractive to the university, and you'll be familiar with this problem in the UK, is that we're quite good. The discovery science here is pretty good.Sir John Bell (08:06):And we do startups now at scale. So Oxford does lots of little startup companies in the biotech space and all the rest of it, but we never scale any of these companies because there isn't the depth of capital for scaling capital to get these things scaled. And so, in a way what we're trying to do here at Ellison actually avoids that problem because Larry knows how to scale companies, and we've got the financial support now. If we have things that are really successful, we can build the full stack solution to some of these problems. So I think the university is really intrigued as to how we might do that. We're going to have to bring some people in that know how to do that and build billion dollar companies, but it's sufficiently attractive. We've already started to recruit some really outstanding people. So as a way to change the UK system broadly, it's actually quite a good disruptive influence on the way the thing works to try and fix some of the fundamental problems.Eric Topol (09:07):I love that model and the ability that you can go from small startups to really transformative companies have any impact. It fits in well with the overall objectives, I can see that. The thing that also is intriguing regarding this whole effort is that in parallel we've learned your influence. The UK is a genomics world leader without any question and no coincidence that that's been your area of emphasis in your career. So we've watched these three initiatives that I think you were involved in the UK Biobank, which has had more impact than any cohort ever assembled. Every day there's another paper using that data that's coming out. There's Genomes England, and then now Our Future Health, which a lot of people don't know about here, which is well into the 5 million people enrollment. Can you tell us about, this is now 15 years ago plus when these were started, and of course now with a new one that's the biggest ever. What was your thinking and involvement and how you built the UK to be a world leader in this space?Sir John Bell (10:26):So if you turn the clock back 20 years, or actually slightly more than 25 years ago, it was clear that genomics was going to have a play. And I think many of us believed that there was going to be a genetic element to most of the major common disease turn out to be true. But at the time, there were a few skeptics, but it seemed to us that there was going to be a genetic story that underpinned an awful lot of human disease and medicine. And we were fortunate because in Oxford as you know, one of my predecessors in the Regius job was Richard Doll, and he built up this fantastic epidemiology capability in Oxford around Richard Peto, Rory Collins, and those folks, and they really knew how to do large scale epidemiology. And one of the things that they'd observed, which is it turns out to be true with genetics as well, is a lot of the effects are relatively small, but they're still quite significant. So you do need large scale cohorts to understand what you're doing. And it was really Richard that pioneered the whole thinking behind that. So when we had another element in the formula, which was the ability to detect genetic variation and put that into the formula, it seemed to me that we could move into an era where you could set up, again, large cohorts, but build into the ability to have DNA, interrogate the DNA, and also ultimately interrogate things like proteomics and metabolomics, which were just in their infancy at that stage.Sir John Bell (12:04):Very early on I got together because I was at that stage at the Nuffield Chair of Medicine, and I got together, Rory and Richard and a couple of others, and we talked a little bit about what it would look like, and we agreed that a half a million people late to middle age, 45 and above would probably over time when you did the power calculations, give you a pretty good insight in most of the major diseases. And then it was really a question of collecting them and storing the samples. So in order to get it funded at the time I was on the council of the MRC and George Radda, who you may remember, was quite a distinguished NMR physiologist here. He was the chief executive of the MRC. So I approached him and I said, look, George, this would be a great thing for us to do in the UK because we have all the clinical records of these people going back for a decade, and will continue to do that.Sir John Bell (13:01):Of course, we immediately sent it out to a peer review committee in the MRC who completely trashed the idea and said, you got to be joking. So I thought, okay, that's how that lasted. And I did say to George, I said, that must mean this is a really good idea because if it had gone straight through peer review, you would've known you were toast. So anyway, I think we had one more swing at peer review and decided in the end that wasn't going to work. In the end, George to his credit, took it to MRC council and we pitched it and everybody thought, what a great idea, let's just get on and do it. And then the Wellcome came in. Mark Walport was at the Wellcome at the time, great guy, and did a really good job at bringing the Wellcome on board.Sir John Bell (13:45):And people forget the quantum of money we had to do this at the time was about 60 million pounds. I mean, it wasn't astonishly small. And then of course we had a couple of wise people who came in to give us advice, and the first thing they said, well, if you ever thought you were really going to be able to do genetics on 500,000 people, forget it. That'll never work. So I thought, okay, I'll just mark that one out. And then they said, and by the way, you shouldn't assume you can get any data from the health service because you'll never be able to collect clinical data on any of these people. So I said, yeah, yeah, okay, I get it. Just give us the money and let us get on. So anyway, it's quite an interesting story. It does show how conservative the community actually is for new ideas.Sir John Bell (14:39):Then I chaired the first science committee, and we decided about a year into it that we really needed the chief executive. So we got Rory Collins to lead it and done it. I sat on the board then for the next 10 years, but well look, it was a great success. And as you say, it is kind of the paradigm for now, large genetic epidemiology cohorts. So then, as you know, I advise government for many years, and David Cameron had just been elected as Prime Minister. This was in about 2010. And at the time I'd been tracking because we had quite a strong genomics program in the Wellcome Trust center, which I'd set up in the university, and we were really interested in the genetics of common disease. It became clear that the price of sequencing and Illumina was now the clear leader in the sequencing space.Sir John Bell (15:39):But it was also clear that Illumina was making significant advances in the price of sequencing because as you remember, the days when it cost $5,000 to do a genome. Anyway, it became clear that they actually had technology that gets you down to a much more sensible price, something like $500 a genome. So I approached David and I said, we are now pretty sure that for many of the rare diseases that you see in clinical practice, there is a genetic answer that can be detected if you sequenced a whole genome. So why don't we set something up in the NHS to provide what was essentially the beginnings of a clinical service to help the parents of kids with various disabilities work out what's going on, what's wrong with their children. And David had had a child with Ohtahara syndrome, which as you know is again, and so David was very, he said, oh God, I'll tell you the story about how awful it was for me and for my wife Samantha.Sir John Bell (16:41):And nobody could tell us anything about what was going on, and we weren't looking for a cure, but it would've really helped if somebody said, we know what it is, we know what the cause is, we'll chip away and maybe there will be something we can do, but at least you know the answer. So anyway, he gave us very strong support and said to the NHS, can you please get on and do it? Again massive resistance, Eric as you can imagine, all the clinical geneticists said, oh my God, what are they doing? It's complete disaster, dah, dah, dah. So anyway, we put on our tin hats and went out and got the thing going. And again, they did a really good job. They got to, their idea was to get a hundred thousand genomes done in a reasonable timeframe. I think five years we set ourselves and the technology advance, people often underestimate the parallel development of technology, which is always going on. And so, that really enabled us to get that done, and it still continues. They're doing a big neonatal program at the moment, which is really exciting. And then I was asked by Theresa May to build a life science strategy because the UK, we do this stuff not as big and broad as America, but for a small country we do life sciences pretty well.Eric Topol (18:02):That's an understatement, by the way. A big understatement.Sir John Bell (18:04):Anyway, so I wrote the strategies in 2017 for Theresa about what we would do as a nation to support life sciences. And it was interesting because I brought a group of pharma companies together to say, look, this is for you guys, so tell us what you want done. We had a series of meetings and what became clear is that they were really interested in where healthcare was going to end up in the next 20 years. And they said, you guys should try and get ahead of that wave. And so, we agreed that one of the domains that really hadn't been explored properly, it was the whole concept of prevention.Sir John Bell (18:45):Early diagnosis and prevention, which they were smart enough to realize that the kind of current paradigm of treating everybody in the last six months of life, you can make money doing that, there's no doubt, but it doesn't really fix the problem. And so, they said, look, we would love it if you created a cohort from the age of 18 that was big enough that we could actually track the trajectories of people with these diseases, identify them at a presymptomatic stage, intervene with preventative therapies, diagnose diseases earlier, and see if we could fundamentally change the whole approach to public health. So we anyway, went back and did the numbers because of course at much wider age group, a lot of people don't get at all sick, but we thought if we collected 5 million people, we would probably have enough. That's 10% of the UK adult population.Sir John Bell (19:37):So anyway, amazingly the government said, off you go. We then had Covid, which as you know, kept you and I busy for a few years before we could get back to it. But then we got at it, and we hired a great guy who had done a bit of this in the UAE, and he came across and we set up a population health recruitment structure, which was community-based. And we rapidly started to recruit people. So we've now got 2.9 million people registered, 2.3 million people consented, and we've got blood in the bank and all the necessary data including questionnaire data for 1.5 million people growing up. So we will get to 5 million and it's amazing.Eric Topol (20:29):It is. It really is, and I'm just blown away by the progress you've made. And what was interesting too, besides you all weren't complacent about, oh, we got this UK Biobank and you just kept forging ahead. And by the way, I really share this importance of finally what has been a fantasy of primary prevention, which never really achieved. It's always, oh, after a heart attack. But that's what I wrote about in the Super Agers book, and I'll get you a copy.Sir John Bell (21:02):No, I know you're a passionate believer in this and we need to do a lot of things. So we need to work out what's the trial protocol for primary prevention. We need to get the regulators on board. We've got to get them to understand that we need diagnostics that define risk, not disease, because that's going to be a key bit of what we're going to try and do. And we need to understand that for a lot of these diseases, you have to intervene quite early to flatten that morbidity curve.Eric Topol (21:32):Yeah, absolutely. What we've learned, for example, from the UK Biobank is not just, of course the genomics that you touched on, but the proteomics, the organ clocks and all these other layers of data. So that gets me to my next topic, which I know you're all over it, which is AI.Eric Topol (21:51):So when I did the NHS review back in 2018, 2019, the group of people which were amazing that I had to work with no doubt why the UK punches well beyond its weight. I had about 50 people, and they just said, you know what? Yeah, we are the world leaders in genomics. We want to be the world leader in AI. Now these days you only hear about US and China, which is ridiculous. And you have perhaps one of the, I would say most formidable groups there with Demis and Google DeepMind, it's just extraordinary. So all the things that the main foci of the Ellison Institute intersect with AI.Sir John Bell (22:36):They do. And we, we've got two underpinning platforms, well actually three underpinning platforms that go across all those domains. Larry was really keen that we became a real leader in AI. So he's funded that with a massive compute capacity. And remember, most universities these days have a hard time competing on compute because it's expensive.Eric Topol (22:57):Oh yeah.Sir John Bell (22:58):So that is a real advantage to us. He's also funded a great team. We've recruited some people from Demis's shop who are obviously outstanding, but also others from around Europe. So we really, we've recruited now about 15 really outstanding machine learning and AI people. And of course, we're now thinking about the other asset that the UK has got, and particularly in the healthcare space is data. So we do have some really unique data sets because those are the three bits of this that you need if you're going to make this work. So we're pretty excited about that as an underpinning bit of the whole Ellison Institute strategy is to fundamentally underpin it with very strong AI. Then the second platform is generative biology or synthetic biology, because this is a field which is sort of, I hesitate to say limped along, but it's lacked a real focus.Sir John Bell (23:59):But we've been able to recruit Jason Chin from the LMB in Cambridge, and he is one of the real dramatic innovators in that space. And we see there's a real opportunity now to synthesize large bits of DNA, introduce them into cells, microbes, use it for a whole variety of different purposes, try and transform plants at a level that people haven't done before. So with AI and synthetic biology, we think we can feed all the main domains above us, and that's another exciting concept to what we're trying to do. But your report on AI was a bit of a turning point for the UK because you did point out to us that we did have a massive opportunity if we got our skates, and we do have talent, but you can't just do it with talent these days, you need compute, and you need data. So we're trying to assemble those things. So we think we'll be a big addition to that globally, hopefully.Eric Topol (25:00):Yeah. Well that's another reason why I am so excited to talk to you and know more about this Ellison Institute just because it's unique. I mean, there are other institutes as like Chan Zuckerberg, the Arc Institute. This is kind of a worldwide trend that we're seeing where great philanthropy investments are being seen outside of government, but none have the computing resources that are being made available nor the ability to recruit the AI scientists that'll help drive this forward. Now, the last topic I want to get into with you today is one that is where you're really grounded in, and that's the immune response.Eric Topol (25:43):So it's pretty darn clear now that, well, in medicine we have nothing. We have the white cell neutrophil to lymphocyte ratio, what a joke. And then on the other hand, we can do T and B cell sequencing repertoires, and we can do all this stuff, autoantibody screens, and the list goes on and on. How are we ever going to make a big dent in health where we know the immune system is such a vital part of this without the ability to check one's immune status at any point in time in a comprehensive way? What are your thoughts about that?Sir John Bell (26:21):Yeah, so you seem to be reading my mind there. We need to recruit you over here because I mean, this is exactly, this is one of our big projects that we've got that we're leaning into, and that is that, and we all experienced in Covid the ins and outs of vaccines, what works, what doesn't work. But what very clear is that we don't really know anything about vaccines. We basically, you put something together and you hope the trial works, you've got no intermediate steps. So we're building a really substantial immunophenotyping capability that will start to interrogate the different arms of the immune response at a molecular level so that we can use a combination of human challenge models. So we've got a big human challenge model facility here, use human challenge models with pathogens and with associated vaccines to try and interrogate which bits of the immune response are responsible for protection or therapy of particular immunologically mediated diseases or infectious diseases.Sir John Bell (27:30):And a crucial bit to that. And one of the reasons people have tried this before, but first of all, the depth at which you can interrogate the immune system has changed a lot recently, you can get a lot more data. But secondly, this is again, where the AI becomes important because it isn't going to be a simple, oh, it's the T-cell, it's going to be, well, it's a bit of the T cells, but it's also a bit of the innate immune response and don't forget mate cells and don't forget a bit of this and that. So we think that if we can assemble the right data set from these structured environments, we can start to predict and anticipate which type of immune response you need to stimulate both for therapy and for protection against disease. And hopefully that will actually create a whole scientific foundation for vaccine development, but also other kinds of immune therapy and things like cancer and potentially autoimmune disease as well. So that's a big push for us. We're just busy. The lab isn't set up. We've got somebody to run the lab now. We've got the human challenge model set up with Andy Pollard and colleagues. So we're building that out. And within six months, I think we'll be starting to collect data. So I'm just kind of hoping we can get the immune system in a bit more structured, because you're absolutely right. It's a bit pin the tail on the donkey at the moment. You have no idea what's actually causing what.Eric Topol (29:02):Yeah. Well, I didn't know about your efforts there, and I applaud that because it seems to me the big miss, the hole and the whole story about how we're going to advanced human health and with the recent breakthroughs in lupus and these various autoimmune diseases by just targeting CD19 B cells and resetting like a Ctrl-Alt-Delete of their immune system.Sir John Bell (29:27):No, it's amazing. And you wouldn't have predicted a lot of this stuff. I think that means that we haven't really got under the skin of the mechanistic events here, and we need to do more to try and get there, but there's steady advance in this field. So I'm pretty optimistic we'll make some headway in this space over the course of the next few years. So we're really excited about that. It's an important piece of the puzzle.Eric Topol (29:53):Yeah. Well, I am really impressed that you got all the bases covered here, and what a really exhilarating chance to kind of peek at what you're doing there. And we're going to be following it. I know I'm going to be following it very closely because I know all the other things that you've been involved with in your colleagues, big impact stuff. You don't take the little swings here. The last thing, maybe to get your comment, we're in a state of profound disruption here where science is getting gutted by a madman and his henchmen, whatever you want to call it, which is really obviously a very serious state. I'm hoping this is a short term hit, but worried that this will have a long, perhaps profound. Any words of encouragement that we're going to get through this from the other side of the pond?Sir John Bell (30:52):Well, I think regardless of the tariffs, the scientific community are a global community. And I think we need to remember that because our mission is a global mission, and we need to lean into that together. First of all, America is such a powerhouse of everything that's been done scientifically in the human health domain. But not only that, but across all the other domains that we work in, we can't really make the kind of progress that we need to without America being part of the agenda. So first of all, a lot of sympathy for you and your colleagues. I know it must be massively destabilizing for you, not be confident that the things that work are there to help you. But I'm pretty confident that this will settle down. Most of the science is for, well, all the science is really for public good, and I think the public recognizes it and they'll notice if it's not being prosecuted in the way that it has to be. And the global science community cannot survive without you. So we're all leaning in behind you, and I hope it will settle. One of my worries is that these things take years to set up and literally hours or minutes to destroy. So we can't afford to take years to set them back up again. So we do need to be a bit careful about that, but I still have huge confidence in what you guys can achieve and we're all behind you.Eric Topol (32:37):Well, that's really helpful getting some words of wisdom from you there, John. So this has been terrific. Thanks so much for joining, getting your perspective on what you're doing, what's important is so essential. And we'll stay tuned for sure.Sir John Bell (32:59):And come and visit us at the EIT, Eric. We'd be glad to see you.*******************************Some of the topics that John and I discussed—immunology, A.I., genomics, and prevention—are emphasized in my new book SUPER AGERS. A quick update: It will have a new cover after making the New York Times Bestseller list and is currently ranked #25 for all books on Amazon. Thanks to so many of you for supporting the book!Here are a few recent podcasts:Dax Shepard: Dr. Mike Sanjay Gupta ***********************Thanks for reading and subscribing to Ground Truths.If you found this interesting please share it!That makes the work involved in putting these together especially worthwhile.All content on Ground Truths— newsletters, analyses, and podcasts—is free, open-access.Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don't hesitate to post comments and give me feedback. Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. Get full access to Ground Truths at erictopol.substack.com/subscribe

This episode of The Naked Scientists was brought to you in partnership with the health foundation Wellcome.In this edition of The Naked Scientists, we return to the world of fungi and why this is one of the most serious health threats you haven't heard of... Like this podcast? Please help us by supporting the Naked Scientists

This episode of The Naked Scientists was brought to you in partnership with the health foundation Wellcome. This week, the first in a two-part series on the hidden world of fungi. What we do - and don't - know about them, and how the fungal landscape is set to shift as our climate changes. Like this podcast? Please help us by supporting the Naked Scientists

Hello all house music lovers ! Wellcome to the Next Episode of House Jam on Data Transmission Radio. I hope You will find cool my unreleased edits . And be ready to listen a few brand new hits. Here they are: Mistier - In You (Lost and Found) LA Rush & Nadine Randle - A Little Like This (Club Mix) Invida , Maneth, Nina Carr - Wicked Game (RADIO EDIT) Huge thanks to James Hype for sharing his edits And finally if you will listen to the end there is surprise from JUMP COMPLETE FT HARRIET ANNABELL with a dope track Crazy Things. Enjoy! ⚡️Like the Show? Click the [Repost] ↻ button so more people can hear it!

What does a pink puppet called Connie have to do with ethics? More than you might think. On this episode, I'm speaking with a lawyer, whose innovative approach to getting employees to engage in ethics, involved turning to something we all know from our childhood, a puppet.Episode SummaryThat lawyer and my guest on this episode is Fraser Simpson, Associate General Counsel at the Wellcome Trust.  He's on the show to me to tell me about a creative and award-winning approach to embedding ethics in organisations. Fraser and the team at Acteon Communications tackled the challenge of inspiring ethical decision-making in a world where written policies often fall short. Their solution? Connie, a hot pink puppet who represents a conscience, prompting employees to ask, "What would Connie do?" Fraser shares how Connie was born from a need to engage employees in meaningful, human-centred conversations about ethics and compliance. We delve into why traditional approaches often fail, how behavioural science can transform organisational cultures, and why creativity is a powerful tool for behaviour change. Whether you're in legal, compliance, or simply curious about innovation in professional settings, Fraser's insights are both practical and inspiring. Throughout our conversation, Fraser illustrates the power of storytelling, humour, and simplicity in sparking conversations that matter. Connie's journey—from a sketch to a living, breathing character—offers lessons for anyone trying to make complex ideas relatable and impactful.Guest BiographyFraser is the Associate General Counsel at the Wellcome Trust, one of the world's largest charitable foundations supporting science to tackle urgent health challenges. Fraser's work that we discuss on the show focuses on developing a business integrity framework that empowers employees to make sound decisions in moments that matter.With a background in law and a passion for creativity, Fraser has pioneered innovative approaches to compliance, including the development of Connie, a hot pink puppet that embodies ethics and inspires employees to think critically.He describes himself as a dad of two first and a lawyer second, drawing on everyday challenges and creativity to influence his professional work.AI-Generated Timestamped Summary of Key Points[00:00:02] Innovative Ethics Solution (14 Minutes)Fraser introduces Connie, a bright pink puppet created to make ethics training engaging and memorable. By using behavioural science, Wellcome Trust demonstrates the power of moving from dry rulebooks to fostering value-driven decisions. [00:14:05] Revolutionizing Ethics Engagement (8 Minutes)The importance of using creativity to influence ethical decision-making, rather than over rigid rules, focusing on empowering employees with adaptable tools. Fraser explains how storytelling helps make ethics relatable and impactful. [00:21:50] Bringing Connie to Life (13 Minutes)Fraser shares the playful inspiration behind Connie's creation, including how a Hetty vacuum cleaner sparked the idea and how he worked with Acteon, a behavioural science-driven agency. Connie balances humour and professionalism to spark meaningful conversations. [00:34:32] Communicating Ethics Through Creativity (11 Minutes)The Compliance team has considered how to deploy multi-sensory strategies, such as tactile tools and music, to make ethics training more engaging. These creative methods integrate ethics seamlessly into employees' daily routines. [00:45:05] Launching Connie and Sustaining Engagement (6 Minutes)Connie's debut redefines compliance training by prioritising empowerment over box-ticking. Strategies like in-person meetings and digital tools ensure Connie stays relevant across the organisation. [00:50:51] Encouraging Ethical Conversations (14 Minutes)Fraser discusses innovative training approaches, such as regular ethical dilemmas and the "What Would Connie Do?" framework. These quick, consistent exercises develop decision-making skills and foster lasting habits. [01:04:50] Balancing Compliance and Personal Accountability (12 Minutes)The conversation highlights the importance of personal agency in decision-making. By promoting thoughtful judgment, the approach helps create a culture of accountability and better choices. [01:16:23] Inclusive and Accessible Communication (12 Minutes)Inclusivity is central to the approach adopted by Wellcome, including the deployment of a Braille Code of Conduct and other accessible formats. Fraser explains how Wellcome developed practical tools, like a mobile app, for use in critical moments. [01:28:34] Connie's Global Reach and Future Potential (10 Minutes)Connie's cross-cultural appeal in compliance training is explored, along with the vision of e-Connie—a virtual companion for ethical decision-making on a global scale.LinksThe Wellcome Trust — https://wellcome.org/ Acteon, the firm that helped to design and develop Connie — https://www.acteoncommunication.com/ Acteon's case study of Connie — https://www.acteoncommunication.com/case-studies/meet-connie-your-conscience/ Sarah Abramson of Acteon pitching the idea of Connie at ECEC, the 2024 European Compliance & Ethics Conference — https://youtu.be/iCf1CklbysQ?si=z5-Vt3xcC2loZLB1&t=1641 Sarah's appearance on this podcast — https://www.humanriskpodcast.com/sarah-abramson-on-speaking-to-the-human/

Recorded December 5th, 2024. A hybrid seminar by Dr Lorraine Grimes (Maynooth University) as part of the Medical and Health Humanities Seminar Series. Bio: Lorraine Grimes is a Postdoctoral Researcher in Applied Social Studies at Maynooth University. Lorraine has a PhD from the National University of Ireland Galway. Her thesis is forthcoming in the form of a monograph with Bloomsbury Academic in 2025 titled ‘Single mothers in Ireland and Britain: Pregnancy, migration and institutionalisation'. Lorraine previously worked with the Digital Repository of Ireland on the Archiving Reproductive Health project which is the subject of this talk. Abstract: Archiving Reproductive Health (ARH) is a Wellcome-funded project coordinated by the Digital Repository of Ireland (DRI), working to preserve digital material created by grassroots organisations working for reproductive justice in Ireland, especially during the 2018 referendum to repeal the Eighth Amendment of the Irish constitution. The project was the first in the world to archive Facebook social media posts. A key part of the project was the archiving of stories posted on a Facebook page called “In Her Shoes”, where people anonymously shared their experiences of being refused abortion care, having to travel or illegally order pills online, and the emotional impact of these experiences. These stories often contained details of traumatic experiences such as sexual assault, obstetric violence and domestic abuse. This talk will introduce the Archiving Reproductive Health Project and archiving sensitive social media material. We will talk about anonymization procedures, coding/cataloguing and developing a self-care protocol and an ethics protocol for the project. Learn more at www.tcd.ie/trinitylongroomhub

Great workshops deliver clarity, improved collaboration, and actionable outcomes.Now, imagine if you and your team could approach every workday with the same high energy and focus as you feel during a great workshop. That's exactly what today's guest is here to help us achieve–building a workshop culture in the workplace.Meet Alison Coward. Alison is the founder of Bracket, a consultancy that partners with ambitious, forward-thinking companies to help them build high-performing team cultures. She is a team culture coach, workshop facilitator, trainer, keynote speaker, and author of “Workshop Culture: A Guide to Building Teams That Thrive” and “A Pocket Guide to Effective Workshops”. Her clients include Google, Meta, Wellcome, and the V&A. With 20 years of experience working in, leading, and facilitating creative teams, Alison is passionate about finding the balance between creativity, productivity, and collaboration so that teams can thrive and do their best work together.In this episode, Alison and I discuss what a workshop culture is, how it differs from traditional workplace models, and how managers can become effective facilitators.She also shares insights into what it looks like for a team to adopt a workshop culture, the behavioral changes that come with this shift, tips for translating workshop principles–like creativity, collaboration, and inclusion—into everyday team practices, and more.Join the conversation now!Get FREE mini-episode guides with the big idea from the week's episode delivered to your inbox when you subscribe to my weekly email.Conversation Topics(00:00) Introduction(02:06) What is a workshop culture?(03:39) Workshop culture vs. traditional work culture(06:12) How managers can become effective facilitators(09:30) Real-world example of a team transitioning to a workshop culture(12:55) Translating big picture ideas into action(14:37) Why every team member is a co-creator of a team culture(17:41) The behavioral changes that come with this cultural shift(21:41) First step in adopting a workshop culture(24:20) How to hold yourself and others accountable for the changes(26:30) A great manager Alison has worked for(27:44) Keep up with Alison(28:14) [Extended Episode Only] The five pillars of a workshop culture(33:26) [Extended Episode Only] What it looks like for teams embracing a workshop cultureAdditional Resources:- Get the extended episode by Joining The Modern Manager Podcast+ Community for just $15 per month- Read the full transcript here- Follow me on Instagram here - Visit my website for more here- Upskill your team here- Subscribe to my YouTube Channel hereKeep up with Alison Coward- Grab a copy of Alison's book: “Workshop Culture: A Guide to Building Teams that Thrive” here- Follow Alison on LinkedIn here- Visit Bracket for more information hereBook Discount: 30% off “Workshop Culture: A Guide to Building Teams That Thrive”Alison is providing members of Podcast+ 30% off her book “Workshop Culture: A Guide to Building Teams That Thrive”. This book will show you how to create a happy and engaged team through small actions which lead to big results. It features a practical and accessible toolkit to help improve your team's performance and productivity.To get this guest bonus and many other member benefits, become a member of The Modern Manager Podcast+ Community.---------------------The Modern Manager is a leadership podcast for rockstar managers who want to create a working environment where people thrive, and great work gets done.Follow The Modern Manager on your favorite podcast platform so you won't miss an episode!

Many non-civil engineers have passed the Civil PE Exam, and our latest guest, Jessica Wellcome, is another awesome example…whose journey is nothing short of inspiring!

A new satire from award winning writer Anita Sullivan, set at a fictional COP conference, with a talking Mosquito. Developed with leading climate scientists.Peter is a hapless politician representing the UK at COP in Paris. Hoping to retire soon – he didn't really want this assignment, but now he's caught like a rabbit in the headlights between the fiercely intelligent business analyst who has taken the place of his usual PA, and the changing landscapes of contemporary politics and climate crisis speak. Will he talk absolute rubbish? Will he keep his job? Will he sell our children's future to the highest bidder? What is African Horse Flu? And can anyone else hear that whining voice?The Mosquito was developed through OKRE Experimental Stories supported by Wellcome, in consultation with Professor Andy Morse (Professor of Climate Impacts at the University of Liverpool) and Dr Omnia El Omrani (Climate and Health Policy Fellow at Imperial College London).Interviews are used with permission from:https://hub.connectingclimateminds.org/lived-experiencesCASTPeter- Robert BathurstThe Mosquito- Laila AljFarah - Laila AljAddy - Audrey BrissonFaith - Ruth EverettMiles - Laurence SaundersThe Volunteer and other roles - Nuhazet Diaz CanoProduction Co-ordinators - Eleri McAuliffe and Noa DowlingSound Design - Catherine RobinsonDirected by John Norton.A BBC Audio Wales production for Radio 4.

Learn more at TheCityLife.org --- Support this podcast: https://podcasters.spotify.com/pod/show/citylifeorg/support

Wellcome to MMP episode 260. Are you ready to rally?

As the Bill & Melinda Gates Foundation absorbs much of the glory and not nearly enough of the blame, the Wellcome Trust has found a way to maintain a much lower profile in the States while they conduct human experiments on a large segment of the population. Investigative journalist Johnny Vedmore from Unlimited Hangout has been on the trail of the murky philanthropic organization for quite some time, watching and reporting back as they launched the operation in early 2020, then later intentionally drove the COVID narrative into a ditch. What do the people behind the Wellcome Trust actually want for humanity, and is it something that really benefits mankind, or is there a much darker agenda that has remained hidden until now? Anarchapulco 2024 Replay: www.Anarchapulco.com Promo Code: MACRO Sponsors: Chemical Free Body: https://www.chemicalfreebody.com Promo Code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold True Hemp Science: https://truehempscience.com/ Haelan: https://haelan951.com/pages/macro Solar Power Lifestyle: https://solarpowerlifestyle.com/ Promo Code: MACRO LegalShield: www.DontGetPushedAround.com EMP Shield: www.EMPShield.com Promo Code: MACRO Christian Yordanov's Detoxification Program: https://members.christianyordanov.com/detox-workshop?coupon=MACRO Privacy Academy: https://privacyacademy.com/step/privacy-action-plan-checkout-2/?ref=5620 Coin Bit App: https://coinbitsapp.com/?ref=0SPP0gjuI68PjGU89wUv Macroaggressions Merch Store: https://www.teepublic.com/stores/macroaggressions?ref_id=22530 LinkTree: linktr.ee/macroaggressions Books: HYPOCRAZY: https://amzn.to/3VsPDp8 Controlled Demolition on Amazon: https://amzn.to/3ufZdzx The Octopus Of Global Control: Amazon: https://amzn.to/3VDWQ5c Barnes & Noble: https://bit.ly/39vdKeQ Online Connection: Link Tree: https://linktr.ee/Macroaggressions Instagram: https://www.instagram.com/macroaggressions_podcast/ Discord Link:  https://discord.gg/4mGzmcFexg Website: www.Macroaggressions.io Facebook: www.facebook.com/theoctopusofglobalcontrol Twitter: www.twitter.com/macroaggressio3 Twitter Handle: @macroaggressio3 Rumble: https://rumble.com/c/c-4728012 The Union Of The Unwanted LinkTree: https://linktr.ee/uotuw RSS FEED: https://uotuw.podbean.com/ Merch Store: https://www.teepublic.com/stores/union-of-the-unwanted?ref_id=22643&utm_campaign=22643&utm_medium=affiliate&utm_source

Transformation Tip: “An open door is a welcome that makes a stranger into a friend”This week's strength: Includer Accept others Show awareness to those who are left out Desire to increase the circle Build a sense of community Can tell you when you might be missing What or who can be added to thisNeeds A high need to feel included Blindspots when overusedIf they see others not including people, they can become judgemental of them Want everyone to value the things they doInclude too many peopleThis may slow down the processUnnecessary complicatednessGood positions for them  Wellcome groups Orientation positionsTransformation Application: Think about your workplace or an environment you are often in, think about someone who is excluded, and practice your inclusion. Connect On Social: Podcast Facebook Page Steve Facebook Steve Instagram Steve LinkedIn Pete Facebook Pete Instagram Pete LinkedIn

When COVID-19 struck, the governments of the world weren't prepared, but Bill Gates and his partners were already in place, ready and waiting to move. The largest and most powerful was the Bill & Melinda Gates Foundation, one of the largest philanthropies in the world. Then there was Gavi, the global vaccine organization that Gates helped to found to inoculate people in low-income nations, and the Wellcome Trust, a British research foundation with a multibillion dollar endowment that had worked with the Gates Foundation in previous years. Finally, there was the Coalition for Epidemic Preparedness Innovations, or CEPI, the international vaccine research and development group that Gates and Wellcome both helped to create in 2017. Today we show you the suspects, their motives, the weapons they used to commit the crimes of the pandemic, and how they will execute the next one. On this episode of the NTEB Prophecy News Podcast, we bring you a shocking story made all the more so by the fact that this information comes to us from a Far Left news outlet. Whatever you think you know about Bill Gates masterplan for world domination is about to get a major upgrade. Today we will show you how Bill Gates and the outlets he has funded have been laboring for decades to implement his dystopian eugenics agenda, and how the manufactured COVID crisis in 2020 was the exactly the opening he needed. The COVID crisis established Bill Gates as the de facto authority who decides how pandemics will be fought in the future. Do you find it a comforting thought that medicines like Paxlovid, Remdesivir, and the COVID shots and boosters, given to you by your doctor actually come from organizations financed and controlled by Bill Gates? Not only that, but every major world government, including the World Health Organization and the United Nations, have already ceded control to these 4 groups created by Bill Gates, and we will prove that today. If you fail to grasp what this Podcast will show you, you will be fatally unprepared when the next pandemic arrives, and it's coming sooner than you think.

Vaughn TAN is a consultant, author, toolmaker, and professor of strategy at University College London. For over a decade, Vaughn has helped businesses, not-for-profits, and government agencies — like the Singapore Government, Wellcome, and Carlyle Group — design themselves to flourish in uncertainty. He wrote The Uncertainty Mindset (a book about uncertainty and innovation organizations) and makes idk (a training tool for productive discomfort). He is currently working on building better strategies for different kinds of not-knowing. Vaughn has a PhD in Organizational Behavior and Sociology from Harvard University and Harvard Business School. He previously worked at Google in California on special projects (including spaceflight and big structured data) and consumer products (including Earth, Maps, and Streetview). Learn more about Vaughn: Vaughn's website ⁠Connect on LinkedIn⁠ ⁠See more of his work⁠ Where to find the hosts: Brian Moon ⁠Brian's website⁠ ⁠Brian's LinkedIn⁠ ⁠Brian's Twitter⁠ Laura Militello ⁠Laura's website⁠ ⁠Laura's LinkedIn⁠ ⁠Laura's Twitter⁠

As we begin a new year, what knowledge will help investors prepare for potential volatility on the one hand and potential for opportunities on the other? Jeff Spiegel, U.S. Head of Thematics, Sector, and International ETFs joins host Oscar Pulido to provide a holistic overview of major investment themes, the emergence of the AI trade, opportunities in medical innovation, and the impact of geopolitical shifts on globalization to help investors navigate the year ahead.Sources: Slalom, “AI's most powerful prompt,” 10/10/23; BlackRock, Morningstar, BlackRock Portfolio Solutions as of June 30, 2022. Starting Portfolio Allocation is representative of advisors' broad asset allocations for equities, based on analysis of 21,276 portfolios over the 12-month trailing period; Inter Press Service News Agency, “The Historic Reversal of Populations,” 08/08/2016; BlackRock, “Diagnosis: Big opportunity in healthcare stocks,” 07/27/2023; Fortune, “Scientists just used A.I. to map a fruit fly's brain. Here's why it's a ‘turning point in neuroscience',” 07/08/2023; Drug Discovery and Development, “The Brain Knowledge Platform aims to illumine the brain's cellular universe,” 06/10/2023; Morgan Stanley, “Why Artificial Intelligence Could Speed Drug Discovery,”09/09/2023; BCG and Wellcome, Unlocking the potential of AI in Drug Discovery,” June 2023; Gartner, “Beyond ChatGPT: The Future of Generative AI for Enterprises,” 01/26/2023; World Economic Forum, “This chart shows the growth of India's economy,” 09/26/2022; The Economic Times, “India set to be world's third-largest economy by 2030: S&P Global,” 10/25/2023; Global Business Intelligence, Bloomberg, as of 10/31/23; Morningstar, as of 10/31/2023.This content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. In the UK and Non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures go to Blackrock.com/corporate/compliance/bid-disclosuresSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The writer and academic Emma Dabiri encourages unruliness in her latest book, Disobedient Bodies. She puts the origins of western beauty ideals under the spotlight and explores ways to rebel against and subvert the current orthodoxy. The book is accompanied by an exhibition, The Cult of Beauty, at the Wellcome Collection from 26 October 2023 to 28 April 2024. It was in the Wellcome's archive that the filmmaker Carol Morley came across the works and writings of the artist Audrey Amiss. In her new film, Typist Artist Pirate King, Morley creates an imaginative tribute to an unjustly neglected and misunderstood artist. The norm in the world of medical research has been the male body, but in her latest work the scientist and author Cat Bohannon focuses exclusively on women. In Eve: How the Female Body Drove 200 million Years of Human Revolution she looks at everything from birth to death. Producer: Katy Hickman

Throughout this podcast series, we've met trailblazing scientists and researchers changing the world, alongside the people who have inspired and contributed to their work.  In this final bonus episode, Julia Gillard, Chair of Wellcome, brings together three experts from the series to reflect on the main themes that have emerged and ask what challenges still lie ahead in the field of global health. When Science Finds a Way is brought to you by Wellcome, an independent global foundation that supports science to solve the urgent health challenges facing everyone. For more information and transcripts visit wellcome.org  

During the Covid-19 pandemic, the benefits of sequencing infectious disease pathogens became more visible than ever before. The possibilities are huge: genomic sequencing is allowing scientists to unlock the secrets of disease prevention, helping dispel myths and stigma around disease outbreaks as well as allowing governments to act in real-time with targeted and often low-cost interventions.  In this episode Alisha speaks to Professor Christian Happi, Director of the African Centre of Excellence for Genomics of Infectious Diseases, about his pioneering use of the technology during the 2014 Ebola outbreak in Nigeria which identified the origin of the virus. They hear from the lead researcher who used sequencing to map a subsequent outbreak in Guinea, changing how healthcare workers understand the disease. When Science Finds a Way is brought to you by Wellcome, an independent global foundation that supports science to solve the urgent health challenges facing everyone. For more information and podcast transcripts visit wellcome.org

Poor mental health has always been associated with lower socio-economic status, but what if you turned the idea on its head and administered cash transfers as a mental health treatment in and of itself? The scientific research community has long grappled with the lack of major breakthroughs in the treatment of mental health disorders. So could cash transfers hold the key to coming up with a universally applicable and low-cost mental health intervention?  In this episode Alisha is in conversation with Professor Vikram Patel, a world leader in global mental health, who explains the challenges researchers have faced globally in the fight against poor mental health, and the potential of using cash transfers. They hear from an early beneficiary of Brazil's Bolsa Familia cash transfer programme and meet the professor developing a pioneering new study with young people in Nepal, South Africa and Colombia. When Science Finds a Way is brought to you by Wellcome, an independent global foundation that supports science to solve the urgent health challenges facing everyone. For more information and podcast transcripts visit wellcome.org 

With rising temperatures and shifting climates imperilling our crops, the food chain – from planting to consumer – is under threat. This could lead to higher food prices, poor nutrition, hunger and migration. Alisha is in conversation with Professor Ruth Defries, a global expert in ecology and sustainable development, to discuss how the world has become reliant on a small number of crops such as corn and rice, leaving us in a vulnerable position if these staples do not grow well as the planet heats. So how can we encourage climate resilience through crop diversity? They hear from a multi-country research project which is exploring whether indigenous crops could hold the key to creating more sustainable food systems, and meet a South African farmer who is helping keep these old growing traditions alive.  When Science Finds a Way is brought to you by Wellcome, an independent global foundation that supports science to solve the urgent health challenges facing everyone. For more information visit wellcome.org

The world's wealthiest medical research foundation, Wellcome Trust, long disguised as an altruistic charity organization committed to helping humanity, has been knee-deep in the COVID corruption and has major and long-lasting ties to the British eugenics movement. With over $40 billion in funds, the organization has invested heavily in vaccine development and has been instrumental in providing shots to the developing world with the help of the Bill & Melinda Gates Foundation. The most concerning aspect might be the development of the Wellcome Leap program that seeks to become the pharmaceutical version of America's DARPA. With seed funding of $300 million and the former heads of DARPA leading the way, will Wellcome Leap become a savior for humanity or the group that extinguished it? Sponsors: Emergency Preparedness Food: www.preparewithmacroaggressions.com Chemical Free Body: https://www.chemicalfreebody.com and use promo code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold True Hemp Science: https://truehempscience.com/ Haelan: https://haelan951.com/pages/macro Solar Power Lifestyle: https://solarpowerlifestyle.com/ Promo Code: MACRO LegalShield: www.DontGetPushedAround.com EMP Shield: www.EMPShield.com Promo Code: MACRO Coin Bit App: https://coinbitsapp.com/?ref=0SPP0gjuI68PjGU89wUv Macroaggressions Merch Store: https://www.teepublic.com/stores/macroaggressions?ref_id=22530 LinkTree: linktr.ee/macroaggressions Books: HYPOCRAZY: https://amzn.to/3VsPDp8 Controlled Demolition on Amazon: https://amzn.to/3ufZdzx The Octopus Of Global Control: Amazon: https://amzn.to/3VDWQ5c Barnes & Noble: https://bit.ly/39vdKeQ Online Connection: Link Tree: https://linktr.ee/Macroaggressions Instagram: https://www.instagram.com/macroaggressions_podcast/ Discord Link:  https://discord.gg/4mGzmcFexg Website: www.theoctopusofglobalcontrol.com Facebook: www.facebook.com/theoctopusofglobalcontrol Twitter: www.twitter.com/macroaggressio3 Twitter Handle: @macroaggressio3 YouTube: www.youtube.com/channel/UCn3

We are a teeming mass of interconnected microbes and the impact of this microscopic universe on our health, our minds, even our moods, is profound. Made in collaboration with Wellcome Collection, Claudia Hammond and an expert panel explore one of the fastest moving areas of science and what it means for modern medicine. Recorded in front of a live audience at Wellcome's Reading Room in London, Claudia discovers how our microbes could be harnessed to improve our mental and physical health. And along with the scientific insights, there are important answers to questions everybody wants to know the answer to, such as why some peoples' “emissions” smell so badly and how having a dog or cat enriches your microbiome. On stage with Claudia are immunologist Professor Sheena Cruickshank from the University of Manchester, microbiologist Professor Glenn Gibson from the University of Reading and neuroscientist Professor John Cryan from University College Cork in Ireland. Produced by: Fiona Hill and Elisabeth Tuohy Studio Engineer: Bob Nettles and Emma Hearth Image: Scanning electron micrograph (SEM) of bacteria cultured from a sample of human faeces. Credit: Steve Gschmeissner/Science Photo Library/Getty Images